Dr Diana Blaydon

Diana Blaydon

Non-clinical Lecturer

Centre for Cell Biology and Cutaneous Research
Blizard Institute

Research

Skin, Epidermal barrier, Monogenic skin conditions, Cell-cell adhesion, 3D models

Skin Models

Interests

Using patient-derived, mutant keratinocytes in monolayer and 3D organotypic skin models to study molecular mechanisms underlying epidermal barrier function.

Publications

solid heart iconPublications of specific relevance to Predictive in vitro Models

2024

Del Caño LR, South AP, O'Toole EA, Kelsell DP and Blaydon DC (2024). A Role for Aquaporin-5 Variants in Regulation of the Actin Cytoskeleton in Non-Epidermolytic Palmoplantar Keratoderma. Elsevier  Journal of Investigative Dermatology  vol. 144, (9) 2092-2096.  
Dulloo I, Tellier M, Levet C, Chikh A, Zhang B, Blaydon DC, Webb CM, Kelsell DP and Freeman M (2024). Cleavage of the pseudoprotease iRhom2 by the signal peptidase complex reveals an ER-to-nucleus signaling pathway. Elsevier  Molecular Cell  vol. 84, (2) 277-292.e9.  

2023

Murtough S, Babu D, Webb CM, Picard HLD, McGinty LA, Chao-Chu J, Pink R, Silver AR, Smart HL, Field JK, Woodland P, Risk JM, Blaydon DC, Pennington DJ and Kelsell DP (2023). Investigating iRHOM2-Associated Transcriptional Changes in Tylosis With Esophageal Cancer. Elsevier  Gastro Hep Advances  vol. 3, (3) 385-395.  
Ustaoglu A, Daudali FA, D’afflitto M, Murtough S, Lee C, Moreno E, Blaydon DC, Kelsell DP, Sifrim D, Woodland P and Peiris M (2023). Identification of novel immune cell signature in gastroesophageal reflux disease: altered mucosal mast cells and dendritic cell profile. Frontiers  Frontiers in Immunology  vol. 14,  

2020

Chao-Chu J, Murtough S, Zaman N, Pennington DJ, Blaydon DC and Kelsell DP (2020). iRHOM2: A Regulator of Palmoplantar Biology, Inflammation, and Viral Susceptibility. Elsevier  Journal of Investigative Dermatology  vol. 141, (4) 722-726.  

2018

Arcidiacono P, Webb CM, Brooke MA, Zhou H, Delaney PJ, Ng K-E, Blaydon DC, Tinker A, Kelsell DP and Chikh A (2018). p63 is a key regulator of iRHOM2 signalling in the keratinocyte stress response. Springer Nature  Nature Communications  vol. 9, (1)  

2017

Maruthappu T, McGinty LA, Blaydon DC, Fell B, Määttä A, Duit R, Hawkins T, Braun KM, Simpson MA, O’Toole EA and Kelsell DP (2017). Recessive Mutation in FAM83G Associated with Palmoplantar Keratoderma and Exuberant Scalp Hair. Elsevier  Journal of Investigative Dermatology  vol. 138, (4) 984-987.  
Maruthappu T, Chikh A, Fell B, Delaney PJ, Brooke MA, Levet C, Moncada-Pazos A, Ishida-Yamamoto A, Blaydon D, Waseem A, Leigh IM, Freeman M and KELSELL DP (2017). Rhomboid family member 2 Regulates cytoskeletal stress associated Keratin 16. Nature Publishing Group  Nature Communications  vol. 8, 14174-14174.  

2016

Pigors M, Sarig O, Heinz L, Plagnol V, Fischer F, Mohamad J, Malchin N, Rajpopat S, Kharfi M, Lestringant GG, Sprecher E, Kelsell DP and Blaydon DC (2016). Loss-of-function mutations in SERPINB8 linked to exfoliative ichthyosis with impaired mechanical stability of intercellular adhesions. Elsevier (Cell Press): 6 month embargo  American Journal of Human Genetics   
Krøigård AB, Hetland LE, Clemmensen O, Blaydon DC, Hertz JM and Bygum A (2016). The first Danish family reported with an AQP5 mutation presenting diffuse non-epidermolytic palmoplantar keratoderma of Bothnian type, hyperhidrosis and frequent Corynebacterium infections: a case report. BMC Dermatology  vol. 16, (1)  

2014

Blaydon DC and Kelsell DP (2014). Defective channels lead to an impaired skin barrier. J Cell Sci  vol. 127, (Pt 20) 4343-4350.  

2013

Blaydon DC, Lind LK, Plagnol V, Linton KJ, Smith FJD, Wilson NJ, McLean WHI, Munro CS, South AP, Leigh IM, O'Toole EA, Lundström A and Kelsell DP (2013). Mutations in AQP5, encoding a water-channel protein, cause autosomal-dominant diffuse nonepidermolytic palmoplantar keratoderma. Am J Hum Genet  vol. 93, (2) 330-335.  
Scott CA, Plagnol V, Nitoiu D, Bland PJ, Blaydon DC, Chronnell CM, Poon DS, Bourn D, Gárdos L, Császár A, Tihanyi M, Rustin M, Burrows NP, Bennett C, Harper JI, Conrad B, Verma IC, Taibjee SM, Moss C, O'Toole EA and Kelsell DP (2013). Targeted sequence capture and high-throughput sequencing in the molecular diagnosis of ichthyosis and other skin diseases. J Invest Dermatol  vol. 133, (2) 573-576.  
Etheridge SL, Brooke MA, Kelsell DP and Blaydon DC (2013). Rhomboid proteins: A role in keratinocyte proliferation and cancer. Cell and Tissue Research  vol. 351, (2) 301-307.  
Scott CA, Plagnol V, Nitoiu D, Bland PJ, Blaydon DC, Chronnell CM, Poon DS, Bourn D, Gárdos L, Császár A, Tihanyi M, Rustin M, Burrows NP, Bennett C, Harper JI, Conrad B, Verma IC, Taibjee SM, Moss C, O'Toole EA and Kelsell DP (2013). Targeted sequence capture and high-throughput sequencing in the molecular diagnosis of ichthyosis and other skin diseases. Journal of Investigative Dermatology  vol. 133, (2) 573-576.  

2012

Blaydon DC, Etheridge SL, Risk JM, Hennies H-C, Gay LJ, Carroll R, Plagnol V, McRonald FE, Stevens HP, Spurr NK, Bishop DT, Ellis A, Jankowski J, Field JK, Leigh IM, South AP and Kelsell DP (2012). RHBDF2 mutations are associated with tylosis, a familial esophageal cancer syndrome. Am J Hum Genet  vol. 90, (2) 340-346.  
Etheridge SL, Brooke MA, Kelsell DP and Blaydon DC (2012). Rhomboid proteins: a role in keratinocyte proliferation and cancer. Cell and Tissue Research  1-7.  

2011

Blaydon DC, Biancheri P, Di W-L, Plagnol V, Cabral RM, Brooke MA, van Heel DA, Ruschendorf F, Toynbee M, Walne A, O'Toole EA, Martin JE, Lindley K, Vulliamy T, Abrams DJ, MacDonald TT, Harper JI and Kelsell DP (2011). Inflammatory skin and bowel disease linked to ADAM17 deletion. N Engl J Med  vol. 365, (16) 1502-1508.  
Blaydon DC, Nitoiu D, Eckl K-M, Cabral RM, Bland P, Hausser I, van Heel DA, Rajpopat S, Fischer J, Oji V, Zvulunov A, Traupe H, Hennies HC and Kelsell DP (2011). Mutations in CSTA, encoding Cystatin A, underlie exfoliative ichthyosis and reveal a role for this protease inhibitor in cell-cell adhesion. Am J Hum Genet  vol. 89, (4) 564-571.  

2008

Ishii Y, Wajid M, Bazzi H, Fantauzzo KA, Barber AG, Blaydon DC, Nam J-S, Yoon JK, Kelsell DP and Christiano AM (2008). Mutations in R-spondin 4 (RSPO4) underlie inherited anonychia. J Invest Dermatol  vol. 128, (4) 867-870.  

2007

Blaydon DC, Philpott MP and Kelsell DP (2007). R-spondins in cutaneous biology: Nails and cancer. Cell Cycle  vol. 6, (8) 895-897.  
Blaydon DC, Philpott MP and Kelsell DP (2007). R-spondins in cutaneous biology: nails and cancer. Cell Cycle  vol. 6, (8) 895-897.  
Teh MT, Blaydon D, Ghali LR, Briggs V, Edmunds S, Pantazi E, Barnes MR, Leigh IM, Kelsell DP and Philpott MP (2007). Role for WNT16B in human epidermal keratinocyte proliferation and differentiation (vol 120, pg 330, 2007). J CELL SCI  vol. 120, (5) 917-917.  
Teh M-T, Blaydon D, Ghali LR, Briggs V, Edmunds S, Pantazi E, Barnes MR, Leigh IM, Kelsell DP and Philpott MP (2007). Role for WNT16B in human epidermal keratinocyte proliferation and differentiation. J Cell Sci  vol. 120, (Pt 2) 330-339.  

2006

Blaydon DC, Ishii Y, O'Toole EA, Unsworth HC, Teh M-T, Rüschendorf F, Sinclair C, Hopsu-Havu VK, Tidman N, Moss C, Watson R, de Berker D, Wajid M, Christiano AM and Kelsell DP (2006). The gene encoding R-spondin 4 (RSPO4), a secreted protein implicated in Wnt signaling, is mutated in inherited anonychia. Nat Genet  vol. 38, (11) 1245-1247.  

2005

Teh M-T, Blaydon D, Chaplin T, Foot NJ, Skoulakis S, Raghavan M, Harwood CA, Proby CM, Philpott MP, Young BD and Kelsell DP (2005). Genomewide single nucleotide polymorphism microarray mapping in basal cell carcinomas unveils uniparental disomy as a key somatic event. Cancer Res  vol. 65, (19) 8597-8603.  

2003

Blaydon DC, Mueller RF, Hutchin TP, Leroy BP, Bhattacharya SS, Bird AC, Malcolm S and Bitner-Glindzicz M (2003). The contribution of USH1C mutations to syndromic and non-syndromic deafness in the UK. Clin Genet  vol. 63, (4) 303-307.  

Grants

solid heart iconGrants of specific relevance to Predictive in vitro Models
bullet iconSwitching of iRhom2 hyperactivity in development of squamous oesophageal cancer
Diana Schalke and David Kelsell
£143,251 Worldwide Cancer Research (01-06-2023 - 31-05-2025)
bullet iconTowards an in vitro model for studying Pachyonychia Congenita
Diana Schalke and David Kelsell
£144,581 Pachyonychia Congenita Project (01-01-2023 - 31-12-2025)


bullet iconDissecting the molecular mechanisms associated with impaired barrier integrity in the oesophageal ep
Diana Schalke and David Kelsell
£41,085 Barts and the London Charity (08-11-2021 - 08-05-2023)